Suppr超能文献

放射治疗联合脑室内注射卡铂治疗脑肿瘤。

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors.

作者信息

Yang Weilian, Barth Rolf F, Huo Tianyao, Nakkula Robin J, Weldon Michael, Gupta Nilendu, Agius Lawrence, Grecula John C

机构信息

Department of Pathology, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Radiat Oncol. 2014 Jan 14;9:25. doi: 10.1186/1748-717X-9-25.

Abstract

BACKGROUND

In this study we determined if treatment combining radiation therapy (RT) with intracerebral (i.c.) administration of carboplatin to F98 glioma bearing rats could improve survival over that previously reported by us with a 15 Gy dose (5 Gy × 3) of 6 MV photons.

METHODS

First, in order to reduce tumor interstitial pressure, a biodistribution study was carried out to determine if pretreatment with dexamethasone alone or in combination with mannitol and furosemide (DMF) would increase carboplatin uptake following convection enhanced delivery (CED). Next, therapy studies were carried out in rats that had received carboplatin either by CED over 30 min (20 μg) or by Alzet pumps over 7 d (84 μg), followed by RT using a LINAC to deliver either 20 Gy (5 Gy × 4) or 15 Gy (7.5 Gy × 2) dose at 6 or 24 hrs after drug administration. Finally, a study was carried out to determine if efficacy could be improved by decreasing the time interval between drug administration and RT.

RESULTS

Tumor carboplatin values for D and DMF-treated rats were 9.4 ± 4.4 and 12.4 ± 3.2 μg/g, respectively, which were not significantly different (P = 0.14). The best survival data were obtained by combining pump delivery with 5 Gy × 4 of X-irradiation with a mean survival time (MST) of 107.7 d and a 43% cure rate vs. 83.6 d with CED vs. 30-35 d for RT alone and 24.6 d for untreated controls. Treatment-related mortality was observed when RT was initiated 6 h after CED of carboplatin and RT was started 7 d after tumor implantation. Dividing carboplatin into two 10 μg doses and RT into two 7.5 Gy fractions, administered 24 hrs later, yielded survival data (MST 82.1 d with a 25% cure rate) equivalent to that previously reported with 5 Gy × 3 and 20 μg of carboplatin.

CONCLUSIONS

Although the best survival data were obtained by pump delivery, CED was highly effective in combination with 20 Gy, or as previously reported, 15 Gy, and the latter would be preferable since it would produce less late tissue effects.

摘要

背景

在本研究中,我们确定了对携带F98胶质瘤的大鼠进行放射治疗(RT)联合脑内(i.c.)给予卡铂的治疗方法是否能比我们之前报道的6兆伏光子15 Gy剂量(5 Gy×3)提高生存率。

方法

首先,为了降低肿瘤间质压力,进行了一项生物分布研究,以确定单独用地塞米松或与甘露醇和呋塞米联合使用(DMF)进行预处理是否会在对流增强递送(CED)后增加卡铂的摄取。接下来,对通过CED在30分钟内给予卡铂(20μg)或通过Alzet泵在7天内给予卡铂(84μg)的大鼠进行治疗研究,然后在给药后6或24小时使用直线加速器进行RT,给予20 Gy(5 Gy×4)或15 Gy(7.5 Gy×2)剂量。最后,进行了一项研究,以确定缩短给药与RT之间的时间间隔是否能提高疗效。

结果

D组和DMF组治疗大鼠的肿瘤卡铂值分别为9.4±4.4和12.4±3.2μg/g,差异无统计学意义(P = 0.14)。通过泵注联合5 Gy×4的X射线照射获得了最佳生存数据,平均生存时间(MST)为107.7天,治愈率为43%;相比之下,CED组的MST为83.6天,单纯RT组为30 - 35天,未治疗对照组为24.6天。当在卡铂CED后6小时开始RT且在肿瘤植入后7天开始RT时,观察到与治疗相关的死亡率。将卡铂分为两个10μg剂量,RT分为两个7.5 Gy分次,在24小时后给予,得到的生存数据(MST 82.1天,治愈率25%)与之前报道的5 Gy×3和20μg卡铂相当。

结论

虽然通过泵注获得了最佳生存数据,但CED与20 Gy联合使用非常有效,或者如之前报道的与15 Gy联合使用也有效,而后者更可取,因为它产生的晚期组织效应较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c37/3898032/858728b41e06/1748-717X-9-25-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验